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Pregnancy is associated with changes in hematological and biochemistry values, yet there
are no African reference intervals for clinical management of pregnant women. We sought
to 1) develop laboratory reference intervals during pregnancy and up to 24 weeks postpar-
tum and 2) determine the proportion of women in a previous clinical trial who would be mis-
classified as having out-of-range values using reference intervals from a United States (U.
S.) population.
Methods and findings
This was a longitudinal sub-study of 120 clinically healthy, HIV-uninfected, self-selected
pregnant women seeking antenatal care services at either of two public hospitals in western
Kenya. Blood specimens were obtained from consented women at gestational ages 28 and
36 weeks and at 2, 6, 14 and 24 weeks postpartum. Median and 95% reference intervals
were calculated for immune-hematological and biochemistry parameters and compared to
reference intervals from a Kenyan and United States (U.S.) population, using Wilcoxon
tests. Differences with p0.05 were considered significant. Some hematological parame-
ters, including hemoglobin and neutrophils showed significant variations compared to refer-
ence intervals for non-pregnant women. Hemoglobin values were significantly lower during
pregnancy but were comparable to the values in non-pregnant women by 6 weeks postpar-
tum. CD4, CD8 and platelets were significantly elevated in early postpartum but declined
gradually, reaching normal levels by 24 weeks postpartum. Using the new hemoglobin refer-
ence levels from this study to estimate prevalence of ‘out of range’ values in a prior Kisumu
research cohort of pregnant/postpartum women, resulted in 0% out of range values, in con-
trast to 96.3% using US non-pregnant reference values
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Conclusion
There were substantial differences in U.S. and Kenyan values for immune-hematological
parameters among pregnant/postpartum women, specifically in red blood cell parameters in
late pregnancy and 2 weeks postpartum. Use of U.S. reference intervals markedly increases
likelihood of out of range values, highlighting the need for suitable locally developed refer-
ence intervals.
Introduction
With the advent of antiretroviral therapy (ART) for HIV and other interventions to improve
maternal and child health, pregnant women and infants are the focus of many health pro-
grams, including prevention of mother-to-child transmission (PMTCT). Recruitment of preg-
nant women into clinical trials and overall clinical management require accurate laboratory
reference intervals for correct interpretation and decision making [1]. Reference intervals
are useful in diagnosis of health disorders, drug toxicity monitoring, disease staging, and mon-
itoring of treatment response. Moreover, recruitment of participants into clinical studies and
the interpretation of results from such studies necessitate the use of appropriate reference
intervals.
While the red cell mass increases during pregnancy, the plasma volume increases more,
resulting in a relative anemia. This leads to lower hemoglobin (Hb) level, hematocrit (Hct)
and red blood cell (RBC) count. However, iron supplementation during pregnancy results in
higher Hb levels than in non-supplemented women, indicating that iron deficient erythropoie-
sis plays a significant role apart from hemodilution [2]. Hb level is known to vary with gesta-
tional age, with the highest values within the first and last trimesters and lowest values during
the second trimester. Similarly, Hct and RBC count decrease with increasing gestational age,
while a stable higher upper reference limit for white blood cell (WBC) count during pregnancy
has been reported [3, 4]. WBC count is known to peak at delivery, thus limiting the use of this
parameter as a marker for infection during delivery. This increase in WBC count results pri-
marily from an increase in neutrophil counts and a slight increase in lymphocyte counts.
Serum biochemistry parameters during pregnancy and postpartum have previously been
reported with mixed results [5–10]. For example, elevated serum alanine transaminase (ALT)
levels was reported in one Swedish study while another showed a decrease during pregnancy
[9, 11].
Currently, no data exist on reference intervals during pregnancy based on African women.
Most laboratory information systems report reference values based on samples obtained from
non—pregnant women, which may not be useful for clinical decisions during pregnancy.
Moreover, some of the reference intervals are derived from western populations that are pre-
dominantly Caucasian, resulting in further misclassification of participants as highlighted by
several African studies [12–16]. In phase I clinical trials—in absence of a control group—this
is a critical issue because otherwise clinically healthy participants are misclassified as having
abnormal values, hence escalating costs in terms of participant recruitment and management
[14]. More importantly, there is also an increased risk of overlooking important physiologic
alterations resulting from pathological conditions and of misinterpreting normal changes as
pathological events [9]. This can lead to unnecessary and potentially dangerous therapeutic
actions without determining the real cause of the abnormality for example, women with
abnormal liver enzyme levels due to pregnancy may be treated for intrahepatic cholestasis of
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pregnancy or pre-eclampsia. Consequently, there is an ongoing need to update reference inter-
vals on the most commonly used immune-hematological and biochemistry variables during
pregnancy and postpartum period. We sought to 1) develop laboratory reference intervals
during pregnancy and up to 6 months postpartum for clinical decision making in western
Kenya and 2) determine the proportion of women in a previous clinical trial of HIV infected
women (Kisumu Breastfeeding Study or KiBS) [17] who would be misclassified as having out-
of-range hemoglobin values using the established reference intervals from a United States
(U.S.) population.
Materials and methods
Participants included in our analyses were recruited from a longitudinal cohort study, the
Mama Salama study, the aims of which were to define the incidence of HIV infection and
identify risk factors associated with HIV infection during peri/postpartum period. Study par-
ticipants comprised pregnant women seeking antenatal care services at two public hospitals in
the former Nyanza Province of Kenya, Bondo County hospital and Ahero sub-County hospital
from May 2011 to July 2014. Women were eligible to participate if they were HIV uninfected
(based on rapid HIV testing and nucleic acid amplification test [NAAT] at enrolment and sub-
sequently negative on NAAT throughout the study), pregnant, with a plan to remain in the
area until at least 9 months postpartum, willing to have serial visits at maternal child health
clinic with serial HIV testing through 9 months postpartum, not on medication that could
alter hematological parameters, and no clinical evidence of malaria and helminth infections.
Blood specimens for hematological and biochemistry values were obtained from consented
women 14 years and above at 28 and 36 weeks gestation as well as at 2, 6, 14 and 24 weeks
postpartum.
Ethical approval
The study and the consenting procedures were approved by the Kenya Medical Research Insti-
tute’s (KEMRI) ethics review committee, University of Nairobi/Kenyatta National Hospital
Ethics and Research Committee (ERC) and University of Washington Institutional Review
Board (IRB). Written informed consent was obtained from participants prior to any study pro-
cedure. All specimens had a unique study identification linked to the main study consent. For
all critical values, participants were referred for clinical management per Kenya standard of
care.
Blood collection and HIV serology
Whole blood was collected in ethylenediaminetetraacetic acid vacutainer tubes (Becton Dick-
inson, Franklin Lakes, NJ) and transported at 4˚C to the KEMRI HIV-research laboratory
within six hours of specimen collection for processing and analysis. Initially, HIV status was
determined using HIV rapid test kits as follows: Determine (Abbot Laboratories, Tokyo,
Japan), and Bioline (Standard Diagnostics Inc., Korea) as a confirmatory test for any positive
specimen and Unigold (Trinity Biotech Plc, Bray, Ireland), as a tie breaker. Later, HIV infec-
tion at enrolment was determined using the new Kenyan testing algorithm, with KHB
(Shangai, Kehua Bioengineering Co. Ltd) as primary kit and First Response (PMC Medical
Pty. Ltd) as the confirmatory kit. Unigold was used as the tie breaker for any specimen with an
indeterminate result.
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Hematological analysis
Absolute WBC counts and percentages for leukocytes with differentials (neutrophils, lympho-
cytes, monocytes, eosinophils, and basophils), RBC with parameters Hb, Hct and mean cell
volume (MCV), and platelet counts were determined from whole blood using a Coulter ACT
5Diff CP analyzer (Beckman Coulter, France). This was performed within 24 hours of speci-
men collection as recommended by the manufacturer (www.beckmancoulter.com).
Biochemistry analysis
Clinical chemistries were analyzed from serum obtained from serum separation tubes (Becton
Dickinson, Franklin Lakes, NJ). Specimens were analyzed for ALT, aspartate aminotransferase
(AST), bilirubin (Bil) and creatinine (Cr) using the Cobas Integra 400 plus biochemistry ana-
lyzer (Roche, Germany) per the manufacturer’s instructions (www.usdiagnostics.roche.com).
Quality control
Quality control protocols included running known standards each day before testing speci-
mens. In addition, the laboratory is enrolled in external quality assurance testing programs
with the College of American Pathologists (CAP) (hematology, and clinical chemistry) and the
United Kingdom National External Quality Assurance Service (UK NEQAS) (lymphocyte
immunophenotyping and hematology). The laboratory has satisfactory performance in UK
NEQAS (Lymphocyte Immunophenotyping) and CAP Clinical Chemistry as well as CAP
Hematology over the past three years.
Statistical analysis
Based on the CLSI guidelines recommendation of 120 reference subjects for establishing refer-
ence intervals and assuming a loss to follow up rate of 20%, 150 pregnant women were targeted
for enrollment. Every 6th woman in the parent study was targeted for enrollment into the refer-
ence interval sub-study. All data available at each time point were entered into an Access
database and the median and 95% reference intervals (2.5 and 97.5 percentiles) for immune-
hematological and biochemistry parameters calculated using SAS (SAS system for Windows
9.2; SAS, Inc., Cary, NC). These values were compared to established reference intervals devel-
oped for non-pregnant women in western Kenya [16], using the Wilcoxon test. Differences
with p0.05 were considered significant.
In order to demonstrate the use of appropriate reference intervals for a given population,
we determined how many of 522 participants in a previous clinical trial, KiBS [17], would have
out-of-range values using the newly established reference intervals in the current study, the
intervals for non-pregnant women in western Kenya and the intervals from a U.S. population
of non-pregnant women [18]. Additionally, we determined the number of women who would
have abnormal values using the 2004 National Institutes of Health Division of AIDS (DAIDS)
toxicity tables [19].
Results
Overall, 120 women from the intended 150 were enrolled into this study because the parent
study ended before achieving its intended sample size of 2000 pregnant women. Age ranged
from 14 to 44 years with a median of 22 years. Of 120 pregnant women enrolled, 32 did not
complete all six study visit measurements (Fig 1).
Their hematologic and biochemistry values were included in the analysis at each time point
available. The 2.5 and 97.5 percentiles for each time period are presented in Table 1.
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The serum biochemistry parameters were similar to those of non-pregnant women
regardless of pregnancy status (Table 1). Serum biochemistry parameters, ALT, AST, Cr
and Bil generally remained unchanged throughout pregnancy and postpartum and were
within the reference intervals limits for non-pregnant women (Table 1). Table 2 summarizes
the number of women in KiBS who would have been considered as having out-of-range
hemoglobin values when reference intervals for pregnancy/postpartum is compared to the
locally established reference intervals and reference intervals from the U.S. population for
non-pregnant women. Overall, 0% of women in KiBS would have out of range values using
this study’s pregnant cohort’s reference ranges, 55 (10.6%) of women in KiBS would be out
of range compared to local non-pregnant reference ranges, and 499 (96.3%) women in KiBS
had at least one out-of-range hemoglobin value using US reference intervals for non-preg-
nant women. Using the locally established reference intervals for non-pregnant women
rather than those specific to pregnancy/postpartum women, at least more than 8% of our
study population would have out-of-range Hb values during late pregnancy. Using the U.S.
non-pregnant population reference intervals, over 96% of pregnant women at 28 or 36 week
gestation would have been considered as having out-of-range values. Furthermore, using
reference data from the 2004 DAIDS toxicity tables, we observed that among pregnant
women at either 28 or 36 weeks gestation, over 76% would have been considered to have
any grade of anemia, and over 25% would have been considered to have anemia grade 3 or
above.
Fig 1. Flow diagram of participants in the study. The sub study assessed every 6th participant in the parent study for eligibility
(254 participants). One hundred and twenty paticipants were enrolled and followed up to 24 weeks postpartum. Of 120 enrolled
participants, 32 did not complete all six study visit measurements due to a number of reasons including participant unable to be
contacted, miscarriage, death, relocation and seroconversion.
https://doi.org/10.1371/journal.pone.0175546.g001
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Using the reference intervals for pregnancy and postpartum from our study, up to 2.2% of
KiBS participants would have been classified as having out-of-range hemoglobin values at any
time point during the postpartum period. Using locally established reference intervals for non-
pregnant women, up to 6.6% of KiBS participants would have been classified as having hemo-
globin values out of range at two weeks postpartum, after which there was no difference
between reference intervals established in the current study and those established for non-
pregnant women. Using reference intervals from a U.S. population, KiBS participants with
out-of-range hemoglobin values decreased over the postpartum period from 65.7% at 2 weeks
to 47.1% at 24 weeks postpartum. Similarly, using the DAIDS toxicity tables, the proportion of
KiBS participants with any grade anemia postpartum decreased from 47.2% 19.3%, and those
with grade 3 and above anemia postpartum decreased from 14.7% to 2.5%.
The upper limit of reference intervals for WBC count was elevated in late pregnancy but
was similar to the levels in non-pregnant women by 6 weeks postpartum. The lower limit of
absolute neutrophil counts was elevated during late pregnancy but was similar to the levels in
non-pregnant women postpartum. Similarly, the lower limits of CD4 and CD8 cells were ele-
vated postpartum and remained as such but resolved by 24 weeks postpartum. Other WBC
differentials remained relatively unchanged during pregnancy and postpartum, and most
parameters were within the reference limits for non-pregnant women (Table 1).
Table 1. Reference intervals for immune-hematological and biochemistry parameters for HIV uninfected women during pregnancy and postpar-
tum compared to non-pregnant women. Kenya and United States, 2012–2015.
Non-Pregnant women Pregnant/postpartum women from this study
Parameter Kenya [16] US [18] Gestation period Postpartum period
Number of participants 140 NA 120 92 88 95 101 99
28 wk 36 wk 2 wk 6 wk 14 wk 24 wk
ALT (U/L) 0–61 0–35 0–26 0–37 0–34 0–40 0–41 0–67
AST (U/L) 0–50 0–35 0–39 0–44 0–41 0–39 0–45 0–46
Bilirubin (μmol/L) 5.1–40.7 5.1–17.0 1.4–26.3 2.2–22.1 1.9–18.6 2.1–17.0 2.3–19.1 1.6–22.0
Cr (μmol/L) 0–113 0–133 0–59 0–67 0–74 0–72 0–75 0–78
Abs CD4 444–1488 404–1612 419–1567 466–1504 630–1741* 641–1720* 578–1880* 483–2086
Abs CD8 211–1078 220–1129 156–1049 195–1765 396–1458* 360–1342* 356–1267* 302–1442
Hct (%) 23.2–44.2 36.0–46.0 21.4–38.1* 17.7–38.6* 21.0–44.4* 26.9–43.7 27.0–44.7 27.4–43.7
Hb (g/dL) 8.0–14.2 12.0–16.0 6.1–13.0* 5.5–12.7* 6.5–14.7* 7.8–14.4 7.9–14.7 8.0–14.6
MCV (fL) 60–93 80–100 58–101 59–99 59–93 59–95 60–92 62–97
RBC (x1012/L) 3.3–5.6 4.0–5.2 2.8–4.8* 2.8–4.9* 2.9–5.8* 3.6–5.7 3.5–5.7 3.7–5.6
WBC (x10^9/L) 3.3–9.3 4.5–11.0 3.6–11.1 3.3–10.7 3.6–8.9 3.2–9.6 2.8–7.9 2.9–10.3
Neut (x10^9) 0.9–5.2 1.8–7.7 1.9–7.1* 2.0–5.7* 1.1–5.5 1.0–5.5 1.0–3.5 1.0–4.4
Monocytes 0.2–0.8 0–0.1 0.1–0.9 0.1–0.8 0.1–0.6 0.1–0.5 0.1–0.5 0.1–0.7
Lymphocyte count 1.1–3.5 0.2–0.4 0.9–3.3 1.2–3.8 1.3–3.9 1.5–3.8 1.4–3.6 1.1–4.1
Basophils 0.02–0.18 0–0.03 0.01–0.12 0.01–0.09 0.02–0.12 0.02–0.16 0.02–0.12 0.02–0.13
Eosinophils (x109/L) 0–1.7 0–0.1 0–0.9 0–1.0 0–1.2 0–1.8 0–1.2 0–1.4
Platelets (x103/μL) 103–390 150–350 98–395 105–425 180–607* 120–443 119–438 133–437
*p0.05 for comparison with non-pregnant reference interval for Kenya
[16]From non-pregnant cohort in Western Kenya (Zeh et al, 2011)
[18]From non-pregnant United States (U.S.) population (Kratz et al, 2004)
Definitions: ALT: alanine transaminase, AST: aspartate transaminase, Bil: bilirubin, Cr: creatinine, Abs: absolute, Hct: hematocrit, Hb: hemoglobin, MCV:
mean corpuscular volume, RBC: red blood cells, WBC: white blood cells, NA: Not available, Neut: neutrophils, Eosn: eosinophils, Plt: platelets, fl:
femtolitres, U/L: microns per litre, g/dl: grams per decilitre.
https://doi.org/10.1371/journal.pone.0175546.t001
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Discussion
Laboratory tests are often requested during pregnancy to exclude pathological complications
that may affect maternal or fetal health. Diagnostic accuracy is based on evaluation of results
in relation to reference values of the local laboratory. Although changes in normal laboratory
values induced by pregnancy are well known, very few studies have been conducted to estab-
lish reference intervals for pregnant women. In this study, we report the 2.5th and 97.5th per-
centiles reference intervals for selected hematologic and biochemistry laboratory parameters
in late pregnancy and up to 24 weeks postpartum. Unlike other African studies [1, 20], this
was a longitudinal study that followed pregnant women from the second trimester of preg-
nancy to 24 weeks postpartum. Establishment of suitable reference intervals for pregnant
and postpartum women has the potential to improve diagnostic quality, which could lead to
increased survival, reducing unnecessary treatment and cost savings.
Hemoglobin and other red blood cell indicators were most affected during pregnancy, con-
sistent with findings from European studies [2, 21]. This is due to normal expansion of plasma
volume during pregnancy with a concomitant lower expansion in red-cell volume [22]. How-
ever, just as observed for African reference values for non-pregnant women, our values were
significantly lower than European intervals for pregnant women [2, 21], reinforcing the need
to have locally established reference intervals for this population. The lower limit for Hb
during pregnancy was significantly lower among Kenyan pregnant women in this study com-
pared to Caucasian women [2, 23]. This may be due to a genetic factor as indicated by lower
values for non-Caucasian pregnant women compared to Caucasian women within the same
Table 2. Comparison of out-of-range values and frequency of adverse events among HIV infected
pregnant/postpartum women in the Kisumu Breastfeeding Study (KiBS) obtained from using locally-
established reference intervals for pregnant and non-pregnant women in Kenya, United States refer-


































Proportion of KiBS cohort out of
range using reference 2004 DAIDS
Toxicity Table [19]
Time point Any Grade Grade 3&4
n % n % n % n % n %
28wk 0 0 55 10.6 499 96.3 397 76.6 141 27.2
36 wk 0 0 41 8.4 469 96.1 376 77.0 124 25.4
2 wk pp 9 1.9 31 6.6 309 65.7 222 47.2 69 14.7
6 wk pp 10 2.2 11 2.4 309 67.6 180 39.4 26 5.7
14 wk pp 7 1.6 7 1.6 266 50.4 115 25.7 15 3.3
24 wk pp 5 1.1 5 1.1 205 47.1 84 19.3 11 2.5
16From non-pregnant cohort in Western Kenya (Zeh et al, 2011)
18From non-pregnant United States (U.S.) population (Kratz et al, 2004)
19From 2004 NIH DAIDS toxicity tables (DAIDS, 2004)
Definitions: US: United States, DAIDS: Division of AIDS, pp: postpartum
https://doi.org/10.1371/journal.pone.0175546.t002
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environment [23]. However, values for African pregnant women is much lower than those of
non-Caucasians indicating that the lower levels observed may be exacerbated by other factors
including malnutrition, malaria or sickle cell disease which are endemic in this region [13, 16].
The MCV was unaffected by pregnancy and remained the same as the levels in non-pregnant
women, indicating that other red blood indices were affected by hemadilution rather than
nutritional deficiencies.
The upper limit of WBC count reference interval was elevated during pregnancy but was
similar to the levels in non-pregnant women by 6 weeks postpartum. This may have been due
to the significant increase in neutrophil count during pregnancy, possibly related to stress
response, redistribution of WBCs between the marginal and circulating pools or pain, nausea,
vomiting, and anxiety in the absence of infection [24]. Other WBC differentials remained rela-
tively unchanged during pregnancy and postpartum and most parameters were within the ref-
erence limits for non-pregnant women. Reference intervals for WBC and neutrophils in the
current study were generally lower than the levels in pregnancy among European women.
This may be attributed to genetic, environmental or dietary factors [25, 26]. Similar to or
study, there was significant elevation of neutrophil counts during late pregnancy which
resolved after delivery [8].
Serum biochemistry parameters, ALT, AST, Cr and Bil generally remained unchanged
throughout pregnancy and postpartum and were within the reference intervals limits for non-
pregnant women. Likewise, serum biochemistry reference intervals were similar to those of
European pregnant women [8] except Bil which had a higher upper limit among pregnant
women in the current study. This may result from RBC hemolysis due to malaria or sickle cell
disease [16]. CD4 and CD8 levels were elevated postpartum compared to the levels in preg-
nancy but by 24 weeks postpartum gradually approached the levels in non-pregnant women.
This unexpected observation has previously not been reported and this difference may be due
to the longitudinal design of this study where the same women are followed from pregnancy to
postpartum compared to majority of studies, which are cross-sectional.
While it is possible that the observed differences between African and Caucasian popula-
tions may be due to differences in pre-analytical factors that may differ from the US and Euro-
pean settings, we would attribute these differences to environmental and genetic factors for
two reasons. Firstly, many studies in the African setting have reported significantly lower
hematologic parameters compared to values obtained from Caucasians [12–16, 27]. Secondly,
within the US setting, lower values have been observed for participants of African descent [23].
Moreover, our group has conducted two studies, one in which specimen were obtained in the
field and transported to the testing laboratory and a second study in which specimen were
drawn from the laboratory setting with no significant differences observed for hematologic
parameters [16, 27]. While parasitic infections like helminth and malaria infections are
endemic within the study region, there were no women with evidence of the former and only 2
cases of the later probably as a result of malaria prophylaxis provided as part of antenatal care.
A limitation of this study is that it did not include a concurrent sample of non-pregnant
women from the same reference population. However, we recently demonstrated that the ref-
erence intervals established for western Kenya [16] are valid for use for a different population
sampled from the same region [24]. Another limitation is that we were unable to recruit
women early enough to capture the first trimester of pregnancy due to the design of the parent
study. Nevertheless, our data represent the first reference intervals developed in Kenya for
potential use locally in the clinical management of women during pregnancy and postpartum
periods.
In conclusion, there were substantial differences in U.S., European and Kenyan reference
values for immune and hematological parameters among pregnant and postpartum women,
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specifically in red blood cell parameters including hemoglobin in late pregnancy and 2 weeks
postpartum. Using U.S. reference intervals for hemoglobin would result in an increase in out-
of-range values among pregnant/postpartum women participating in a previous clinical trial
highlighting the suitability of locally developed reference intervals. In the present study, we
have established reference intervals for a number of hematological and biochemistry variables
in healthy pregnant women that can be used for clinical management and recruitment into
clinical trials in western Kenya. These values should be considered for development of region
specific reference intervals and toxicity tables for pregnancy/postpartum women in Africa.
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